|4Sep 13, 4:23 PM ET

Alland Leila 4

4 · PMV Pharmaceuticals, Inc. · Filed Sep 13, 2022

Insider Transaction Report

Form 4
Period: 2022-09-09
Alland Leila
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-09-09+52,20052,200 total
Footnotes (1)
  • [F1]The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION